发明名称 Azaindoles useful as inhibitors of JAK and other protein kinases
摘要 The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
申请公布号 US8987454(B2) 申请公布日期 2015.03.24
申请号 US201414182517 申请日期 2014.02.18
申请人 Vertex Pharmaceuticals Incorporated 发明人 Salituro Francesco;Farmer Luc;Bethiel Randy;Harrington Edmund;Green Jeremy;Court John;Come Jon;Lauffer David;Aronov Alex;Binch Hayley;Boyall Dean;Charrier Jean-Damien;Everitt Simon;Fraysse Damien;Mortimore Michael;Pierard Francoise;Robinson Daniel;Wang Jian;Pinder Joanne;Wang Tiansheng;Pierce Albert
分类号 C07D471/02;C07D471/04;A61K31/437;A61K31/496;A61K31/506;A61K31/5377;A61K31/55;A61K31/551;A61K45/06 主分类号 C07D471/02
代理机构 Honigman Miller Schwartz and Cohn LLP 代理人 Honigman Miller Schwartz and Cohn LLP ;Weber Andrew N.;O'Brien Jonathan P.
主权项 1. A compound of formula I-C:or pharmaceutically acceptable salts thereof, wherein: R1 is T-R′ or is —Si(R′)3; R2, R3, and R4 are each independently halogen, —CN, —NO2, or V—R′; x is 1, 2, 3, or 4; each occurrence of R5 is independently halogen, —CN, —NO2, or U—R′, wherein at least one R5 is other than H; T, V, and U are each independently a bond or an optionally substituted C1-C6 alkylidene chain, wherein up to two methylene units of the chain are optionally and independently replaced by —NR′—, —S—, —O—, —CS—, —CO2—, —OCO—, —CO—, —COCO—, —CONR′—, —NR′CO—, —NR′CO2—, —SO2NR′—, —NR′SO2—, —CONR′NR′—, —NR′—, —OCONR′—, —OCONR′—, —NR′NR′—, —NR′SO2NR′—, —SO—, —SO2—, —PO—, —PO2—, or —POR′—; and each occurrence of R′ is independently hydrogen or an optionally substituted group selected from a C1-C6 aliphatic group, a 3-8-membered saturated, partially unsaturated, or fully unsaturated monocyclic ring having 0-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-12 membered saturated, partially unsaturated, or fully unsaturated bicyclic ring system having 0-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or two occurrences of R′, are taken together with the atom(s) to which they are bound to form an optionally substituted 3-12 membered saturated, partially unsaturated, or fully unsaturated monocyclic or bicyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, provided that: a) if R1 is substituted cyclopentyl, x is 1, and R5 is not fluoro or OMe;b) if R2 and R3 are simultaneously H and R1 and R4 are independently selected from H or Me, x is 1, and R5 is not OMe, NO2, or fluoro;c) if R2, R3 and R4 are simultaneously H, and two R5 form a fused optionally substituted bicyclic ring with the ring to which they are attached, then R1 is not CH2CH2N(Me)2;d) if R2 and R3 are simultaneously H, R4 is NH2, then R1 is not substituted phenyl;e) if R2, R3 and R4 are simultaneously H, then R1 is not Si(R′)3; andf) if R1, R2 and R4 are simultaneously H, then R3 is not phenyl or phenyl substituted with O-phenyl or N(Me)2.
地址 Boston MA US